DrugPatentWatch Database Preview
Drugs in MeSH Category Teratogens
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Douglas Pharms | MYORISAN | isotretinoin | CAPSULE;ORAL | 076485-002 | Jan 19, 2012 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-005 | Aug 15, 2014 | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Sun Pharm | ABSORICA LD | isotretinoin | CAPSULE;ORAL | 211913-005 | Nov 5, 2019 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Sun Pharm | ABSORICA LD | isotretinoin | CAPSULE;ORAL | 211913-006 | Nov 5, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
